Literature DB >> 21406733

Field evaluation of lambda-cyhalothrin (ICON 10 CS) indoor residual spraying against Anopheles culicifacies in India.

K Raghavendra1, S K Ghosh, Alex Eapen, S N Tiwari, T S Satyanarayan, John Ravindran, U Sreehari, A P Dash.   

Abstract

BACKGROUND &
OBJECTIVES: Field trials of lambda-cyhalothrin 10 CS (ICON 10 CS) in indoor residual spraying (IRS) with 25 mg a.i./m2 against Anopheles culicifacies was undertaken vs malathion IRS (25% WP-2 g a.i./m2) in Tumkur district, Karnataka; vs deltamethrin IRS (2.5% WP-20 mg a.i./m2) in Dharmapuri district; and vs lambda-cyhalothrin (10 WP-25 mg a.i./m2) in Ramanathapuram district, Tamil Nadu, India.
METHODS: Spray operations in the experimental villages were done by the National Institute of Malaria Research (NIMR) and in the control villages by the respective State Health Department staff. Persistence of efficacy of insecticide sprayed in villages was assessed by contact bioassays against vector mosquitoes. Entomological indicators such as per structure density, parity rates of vector mosquitoes and sporozoite rates were measured in all the three study areas using standard procedures. Mass blood surveys and active fever case detections were carried out in experimental and control villages to study the impact of IRS on malaria transmission.
RESULTS: Persistence of effectiveness of ICON 10 CS was observed up to 2-3 months in all the three study areas. ICON 10 CS was found effective at par with or better than the insecticides used in the national programme in reducing the mosquito densities and in interrupting malaria transmission in the study villages. Vector density, parity rates and malaria cases considerably reduced in the ICON 10 CS-sprayed villages.
CONCLUSION: Field trials at three sites have established that ICON 10 CS formulation was relatively more effective than malathion 25% WP, deltamethrin 2.5% WP and lambda-cyhalothrin 10% WP in some evaluation parameters like indoor resting mosquitoes, parity rates in vector mosquitoes and persistence of effectiveness. It can be used for IRS for malaria vector control with two rounds of spray at an interval of 3 months for curtailing the malaria transmission and an additional round is recommended in perennial malaria transmission areas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21406733

Source DB:  PubMed          Journal:  J Vector Borne Dis        ISSN: 0972-9062            Impact factor:   1.688


  10 in total

1.  Expression profile of genes during resistance reversal in a temephos selected strain of the dengue vector, Aedes aegypti.

Authors:  Clare Strode; Maria de Melo-Santos; Tereza Magalhães; Ana Araújo; Contancia Ayres
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

2.  Variations of insecticide residual bio-efficacy on different types of walls: results from a community-based trial in south Cameroon.

Authors:  Josiane Etang; Philippe Nwane; Jean Arthur Mbida; Michael Piameu; Blaise Manga; Daniel Souop; Parfait Awono-Ambene
Journal:  Malar J       Date:  2011-11-02       Impact factor: 2.979

3.  Malaria elimination in Botswana, 2012-2014: achievements and challenges.

Authors:  Simon Chihanga; Ubydul Haque; Emmanuel Chanda; Tjantilili Mosweunyane; Kense Moakofhi; Haruna Baba Jibril; Mpho Motlaleng; Wenyi Zhang; Gregory E Glass
Journal:  Parasit Vectors       Date:  2016-02-24       Impact factor: 3.876

4.  Storage and persistence of a candidate fungal biopesticide for use against adult malaria vectors.

Authors:  Simon Blanford; Nina E Jenkins; Riann Christian; Brian H K Chan; Luisa Nardini; Michael Osae; Lizette Koekemoer; Maureen Coetzee; Andrew F Read; Matthew B Thomas
Journal:  Malar J       Date:  2012-10-25       Impact factor: 2.979

5.  Insecticidal decay effects of long-lasting insecticide nets and indoor residual spraying on Anopheles gambiae and Anopheles arabiensis in Western Kenya.

Authors:  Christine L Wanjala; Guofa Zhou; Jernard Mbugi; Jemimah Simbauni; Yaw A Afrane; Ednah Ototo; Maxwell Gesuge; Harrysone Atieli; Andrew K Githeko; Guiyun Yan
Journal:  Parasit Vectors       Date:  2015-11-14       Impact factor: 3.876

6.  A new long-lasting indoor residual formulation of the organophosphate insecticide pirimiphos methyl for prolonged control of pyrethroid-resistant mosquitoes: an experimental hut trial in Benin.

Authors:  Mark Rowland; Pelagie Boko; Abibatou Odjo; Alex Asidi; Martin Akogbeto; Raphael N'Guessan
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

7.  Indoor residual spraying with microencapsulated DEET repellent (N, N-diethyl-m-toluamide) for control of Anopheles arabiensis and Culex quinquefasciatus.

Authors:  Jovin Kitau; Richard Oxborough; Johnson Matowo; Franklin Mosha; Stephen M Magesa; Mark Rowland
Journal:  Parasit Vectors       Date:  2014-09-23       Impact factor: 3.876

8.  Multi-country assessment of residual bio-efficacy of insecticides used for indoor residual spraying in malaria control on different surface types: results from program monitoring in 17 PMI/USAID-supported IRS countries.

Authors:  Dereje Dengela; Aklilu Seyoum; Bradford Lucas; Benjamin Johns; Kristen George; Allison Belemvire; Angela Caranci; Laura C Norris; Christen M Fornadel
Journal:  Parasit Vectors       Date:  2018-01-30       Impact factor: 3.876

9.  Evaluation of the long-term efficacy of K-Othrine® PolyZone on three surfaces against laboratory reared Anopheles gambiae in semi-field conditions.

Authors:  James C Dunford; Alden S Estep; Christy M Waits; Alec G Richardson; David F Hoel; Karin Horn; Todd W Walker; Jessika S Blersch; Jerry D Kerce; Robert A Wirtz
Journal:  Malar J       Date:  2018-02-23       Impact factor: 2.979

10.  Indoor and outdoor residual spraying of a novel formulation of deltamethrin K-Othrine® (Polyzone) for the control of simian malaria in Sabah, Malaysia.

Authors:  A Rohani; H Ahmad Fakhriy; I Suzilah; M N Zurainee; W M A Wan Najdah; M Mohd Ariffin; N Mohamad Shakirudin; M S Mohd Afiq; J Jenarun; Y Tanrang; H L Lee
Journal:  PLoS One       Date:  2020-05-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.